BPC-157 vs TB-500.
BPC-157 and TB-500 are research peptides that are often discussed together for tissue repair. They come from different proteins and have mostly been studied in animals and cells. Neither is an FDA-approved drug, and both are banned in sport.
| BPC-157 | TB-500 | |
|---|---|---|
| Based on | A sequence from a protein in gastric juice | Part of Thymosin Beta-4, a protein involved in cell movement and repair |
| What research covers | Tendon, ligament and gut tissue, mostly animal and lab studies | Cell migration and tissue repair, mostly animal and cell studies |
| Human evidence | Limited | Limited |
| US status | Not FDA-approved | Not FDA-approved |
| July 2026 advisory vote | Favorable, non-binding; FDA decision pending | Favorable, non-binding; FDA decision pending |
| Sport | Prohibited (WADA) | Prohibited (WADA) |
Different origins, similar reputation
BPC-157 is a 15-amino-acid synthetic peptide modeled on a sequence from a gastric protein. TB-500 is a synthetic peptide based on part of Thymosin Beta-4. Both are promoted for recovery, but the evidence behind that comes mostly from animal and laboratory research, not controlled human trials.
Regulatory status in 2026
In April 2026 the FDA removed both from its Category 2 list of bulk substances with safety concerns. On July 23-24, 2026 its Pharmacy Compounding Advisory Committee voted, in a non-binding vote, in favor of allowing both in compounding. The FDA has not made a final decision, and neither is an approved drug.
Tracking either one
Each peptide needs its own record: vial strength and water added, the resulting units per dose, time and injection site, cycle length and vial inventory. Keeping them as separate items shows exactly what was taken and when.
Common questions.
What is the difference between BPC-157 and TB-500?
They come from different proteins: BPC-157 from a gastric protein sequence, TB-500 from Thymosin Beta-4. Both are studied mainly in animals for tissue repair, and neither is FDA-approved.
Is BPC-157 or TB-500 better?
There are no controlled human trials comparing them, so there is no evidence-based answer. Talk to a licensed provider before using any unapproved substance.
Are BPC-157 and TB-500 legal?
As of September 2026, neither is FDA-approved. Both received a favorable, non-binding advisory committee vote on compounding in July 2026, and the FDA decision is pending.
Can PRTCL track BPC-157 and TB-500 together?
Yes. Each gets its own schedule, reconstitution math and site rotation, and they can sit side by side in one daily view.
Track it in one system.
PRTCL runs peptides, supplements, nutrition and training together, with reminders at the times you set, reconstitution math, site rotation and inventory that counts itself down. Launching on Android and iPhone the same day. Join the waitlist and enter the draw for one of 57 lifetime Premium subscriptions.